| 000 | 01725 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250513145412.0 | ||
| 264 | 0 | _c19981006 | |
| 008 | 199810s 0 0 eng d | ||
| 022 | _a0306-5251 | ||
| 024 | 7 |
_a10.1046/j.1365-2125.1998.00729.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBitsios, P | |
| 245 | 0 | 0 |
_aComparison of the effects of moclobemide and selegiline on tyramine-evoked mydriasis in man. _h[electronic resource] |
| 260 |
_bBritish journal of clinical pharmacology _cJun 1998 |
||
| 300 |
_a551-8 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAnalysis of Variance |
| 650 | 0 | 4 |
_aBenzamides _xadministration & dosage |
| 650 | 0 | 4 |
_aBlood Platelets _xmetabolism |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 | _aDrug Interactions |
| 650 | 0 | 4 | _aFeasibility Studies |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMeiosis _xdrug effects |
| 650 | 0 | 4 | _aMoclobemide |
| 650 | 0 | 4 |
_aMonoamine Oxidase _xmetabolism |
| 650 | 0 | 4 |
_aMonoamine Oxidase Inhibitors _xadministration & dosage |
| 650 | 0 | 4 |
_aNaphthols _xblood |
| 650 | 0 | 4 |
_aPropylene Glycols _xblood |
| 650 | 0 | 4 |
_aPupil _xdrug effects |
| 650 | 0 | 4 |
_aSelegiline _xadministration & dosage |
| 650 | 0 | 4 |
_aTyramine _xpharmacology |
| 700 | 1 | _aLangley, R W | |
| 700 | 1 | _aTavernor, S | |
| 700 | 1 | _aPyykkö, K | |
| 700 | 1 | _aScheinin, M | |
| 700 | 1 | _aSzabadi, E | |
| 700 | 1 | _aBradshaw, C M | |
| 773 | 0 |
_tBritish journal of clinical pharmacology _gvol. 45 _gno. 6 _gp. 551-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1046/j.1365-2125.1998.00729.x _zAvailable from publisher's website |
| 999 |
_c9629830 _d9629830 |
||